Manulife (Manufacturers Life Insurance)
STOK icon

Manulife (Manufacturers Life Insurance)’s Stoke Therapeutics STOK Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Buy
69,222
+55,672
+411% +$1.83M ﹤0.01% 1450
2025
Q4 		$430K Sell
13,550
-1,494
-10% -$44.9K ﹤0.01% 2243
2025
Q3 		$354K Sell
15,044
-55
-0.4% -$942 ﹤0.01% 2328
2025
Q2 		$171K Buy
15,099
+1,862
+14% +$17.7K ﹤0.01% 2616
2025
Q1 		$88K Sell
13,237
-67
-0.5% -$625 ﹤0.01% 2728
2024
Q4 		$147K Sell
13,304
-314
-2% -$3.86K ﹤0.01% 2726
2024
Q3 		$167K Sell
13,618
-346
-2% -$4.9K ﹤0.01% 2727
2024
Q2 		$189K Buy
13,964
+1,994
+17% +$26.9K ﹤0.01% 2627
2024
Q1 		$162K Buy
11,970
+54
+0.5% +$327 ﹤0.01% 2669
2023
Q4 		$62.7K Hold
11,916
– – ﹤0.01% 2903
2023
Q3 		$46.9K Sell
11,916
-35,355
-75% -$232K ﹤0.01% 2944
2023
Q2 		$502K Buy
47,271
+2,119
+5% +$22.5K ﹤0.01% 2033
2023
Q1 		$376K Hold
45,152
– – ﹤0.01% 2183
2022
Q4 		$410K Sell
45,152
-33
-0.1% -$343 ﹤0.01% 2115
2022
Q3 		$587K Sell
45,185
-344
-0.8% -$5.48K ﹤0.01% 1873
2022
Q2 		$603K Buy
45,529
+11,030
+32% +$168K ﹤0.01% 1917
2022
Q1 		$755K Buy
34,499
+23,598
+216% +$473K ﹤0.01% 1919
2021
Q4 		$262 Buy
10,901
+218
+2% +$5.2K ﹤0.01% 2712
2021
Q3 		$272K Sell
10,683
-757
-7% -$21.1K ﹤0.01% 2751
2021
Q2 		$385K Buy
11,440
+3,244
+40% +$115K ﹤0.01% 2615
2021
Q1 		$318K Buy
8,196
+300
+4% +$17.1K ﹤0.01% 2577
2020
Q4 		$489K Buy
7,896
+276
+4% +$12.7K ﹤0.01% 2208
2020
Q3 		$255K Buy
+7,620
New +$218K ﹤0.01% 2410
2020
Q2 		– Sell
-10,603
Closed -$243K – 2922
2020
Q1 		$243K Buy
+10,603
New +$262K ﹤0.01% 2209

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s STOK Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Stoke Therapeutics (STOK) stake by 411% in Q1 2026, buying an estimated $1.83M and bringing the position to 69,222 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

Manulife (Manufacturers Life Insurance) first reported a position in STOK in Q1 2020 and has held it in 24 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 69,222 shares of Stoke Therapeutics worth $2.25M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 55,672 Stoke Therapeutics shares in Q1 2026, an estimated $1.83M.
  • Stoke Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1450 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 24 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.